Filing Details
- Accession Number:
- 0001127602-10-026087
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-10-27 19:35:17
- Reporting Period:
- 2010-10-26
- Filing Date:
- 2010-10-27
- Accepted Time:
- 2010-10-27 19:35:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 318154 | Amgen Inc | AMGN | Biological Products, (No Disgnostic Substances) (2836) | 953540776 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1199306 | Anna Richo | One Amgen Center Drive Thousand Oaks CA 91320-1799 | Svp & Cco | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-10-26 | 5,900 | $42.13 | 20,161 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-10-26 | 5,900 | $56.94 | 14,261 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Nqso (Right to Buy) | Disposition | 2010-10-26 | 5,900 | $0.00 | 5,900 | $42.13 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,900 | 2009-04-29 | 2015-04-29 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,001 | Indirect | 401(k) Plan |
| Common Stock | 2,607 | Indirect | The Nicholas A. Moore and Anna S. Richo Family Trust |
Footnotes
- The price reported is an average price. The prices ranged from $56.9400 to $56.9420 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
- These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,500 RSUs which vest on 7/31/2011; 1,686 RSUs which vest in two equal annual installments of 843 each commencing 4/29/2011; 4,275 RSUs which vest in three equal annual installments of 1,425 each commencing 4/28/2011; and 5,800 RSUs which vest in four equal annual installments of 1,450 each commencing 4/26/2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
- This option is exercisable in four equal annual installments of 2,950 each commencing April 29, 2009.
Billionaire Hedge Funds
